| Ytd | -63.69% | |
| 1y | -63.47% |
| Open | 4.55 | Prev Close | 4.56 | Low | 4.20 | High | 4.55 | Mkt Cap | 420.66M |
| Vol | 1.26M | Avg Vol | 1.86M | EPS | -2.18 | P/E | N/A | Forward P/E | -11.01 |
| Beta | 0.83 | Short Ratio | 13.70 | Inst. Own | 95.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 5.15 | 200-d Avg | 7.99 | 1yr Est | 28.80 |
[url="]Schall, Brown and Schwartz LLP[/url] (âSBSâ), a national shareholder rights litigation fi
LOS ANGELES--(BUSINESS WIRE)---- $SPRY--SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals,
NEW YORK--(BUSINESS WIRE)---- $SPRY #ARS--Faruqi & Faruqi, LLP, a leading national securities law fi
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS
ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss
NEW YORK, Oct. 5, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit
LOS ANGELES, Oct. 5, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national sharehold
New York, New York--(Newsfile Corp. - October 4, 2026) - WHY: Rosen Law Firm, a global investor righ
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
U.S. stock futures mixed, Dow down 0.1%. Swarmer Inc (NASDAQ: SWMR) shares drop 7% after reporting w
Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results
ARS Pharmaceuticals (NASDAQ:SPRY) reported second-quarter financial results on Thursday. The transcr
Gainers Akanda (NASDAQ:AKAN) stock rose 109.4% to $10.49 during Thursday's after-market session
ARS Pharmaceuticals (NASDAQ:SPRY) reported quarterly losses of $(0.63) per share which missed the an
ARS Pharma (SPRY) co-founder Richard Lowenthal steps down as CEO. President Donn Casale succeeds him
ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-ris
Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected f
ARS Pharma reaffirmed its 2027 breakeven target, cut expenses and gained Florida Medicaid access for
Gainers Atlantic International (NASDAQ:ATLN) shares increased by 41.0% to $1.1 during Thursday'
U.S. stocks traded mostly higher, with the Nasdaq Composite down 0.1%. Industrials jumped 2.5%, whil
Leerink Partners analyst Roanna Ruiz maintains ARS Pharmaceuticals (NASDAQ:SPRY) with a Outperfor
U.S. stock futures up, Nasdaq 100 futures gain 2%. H.B. Fuller shares dip 8.3% on earnings release a
Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-m
Shares of Micron Technology Inc (NASDAQ: MU) surged in pre-market trading after reporting strong Q3
SPRY stock drops after ARS says no new neffy coverage decisions in July formulary cycle.
Gainers American Shared Hospital (AMEX:AMS) stock rose 14.2% to $1.61 during Wednesday's after-
No new commercial formulary additions or coverage decisions issued for neffy (epinephrine nasal spra
Access and payer coverage: Despite certain payer discussions ongoing until mid-June, based on recent
Cantor Fitzgerald analyst Josh Schimmer maintains ARS Pharmaceuticals (NASDAQ:SPRY) with a Overwe
ARS Pharmaceuticals (NASDAQ:SPRY) reported quarterly losses of $(0.61) per share which missed the an
ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) to release first quarter earnings on May 15 before opening
The CNN Business Fear & Greed Index, a measure of market sentiment, improved slightly on Thursda
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY), a biopharmaceutical company dedicated to empowering patient
"The approval of neffy by Health Canada marks a meaningful advancement for the more than 2.5 mil
Children were previously required to weigh ≥33 lbs. and <66 lbs. and be at least four years of ag
Olaplex Holdings shares surge 51% after being acquired by Henkel AG & Co. KGaA. Other big gainer
ARS Pharmaceuticals (NASDAQ:SPRY) reported quarterly losses of $(0.42) per share which beat the anal